Effect of domperidone-induced hyperprolactinaemia on the menstrual cycle; a placebo-controlled study

In: Journal of Obstetrics and Gynaecology · 1985 · vol. 5(4) , pp. 263–264 · doi:10.3109/01443618509067772 · W2145039037
OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-02 ⓘ

This placebo-controlled study investigated the effect of domperidone-induced hyperprolactinemia on the menstrual cycle to evaluate its potential for fertility control.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PHARMACOLOGICALLY induced hyperprolactin- aemia may be useful for fertility control, parti- cularly during breast-feeding (Bonnar et aZ., 1975). Sulpiride, tiapride, thyrotropin releasing hormone and metoclopramide have been re- ported to produce effects on the menstrual cycle ranging from minimal disturbance to anovula- tion. Domperidone, a dopamine receptor antagonist which does not cross the blood-brain barrier and has few side effects, causes a greater than 10-fold increase in serum prolactin levels in female subjects (Brouwers et aL, 1980). We have studied its potential for fertility control. METHODS

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK